Up-regulation of cytosolic phospholipase A{sub 2}{alpha} expression by N,N-diethyldithiocarbamate in PC12 cells; involvement of reactive oxygen species and nitric oxide
- Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, Chiba University, Inohana 1-8-1, Chuo-ku, Chiba 260-8675 (Japan)
- Department of Health Sciences, Hokkaido University School of Medicine, Sapporo 060-0812 (Japan)
Disulfiram (an alcohol-aversive drug) and related compounds are known to provoke several side effects involving behavioral and neurological complications. N,N-diethyldithiocarbamate (DDC) is considered as one of the main toxic species of disulfiram and acts as an inhibitor of superoxide dismutase. Since arachidonic acid (AA) formation is regulated by reactive oxygen species (ROS) and related to toxicity in neuronal cells, we investigated the effects of DDC on AA release and expression of the {alpha} type of cytosolic phospholipase A{sub 2} (cPLA{sub 2}{alpha}) in PC12 cells. Treatment with 80-120 {mu}M DDC that causes a moderate increase in ROS levels without cell toxicity stimulated cPLA{sub 2}{alpha} mRNA and its protein expression. The expression was mediated by extracellular-signal-regulated kinase (ERK1/2), one of the mitogen-activated protein kinases. Treatment with N {sup G} nitro-L-arginine methyl ester (an inhibitor of nitric oxide synthase, 1 mM) and oxy-hemoglobin (a scavenger of nitric oxide, 2 mg/mL) abolished the DDC-induced responses (ERK1/2 phosphorylation and cPLA{sub 2}{alpha} expression). We also showed DDC-induced up-regulation of the mRNA expression of lipocortin 1, an inhibitor of PLA{sub 2}. Furthermore, DDC treatment of the cells enhanced Ca{sup 2+}-ionophore-induced AA release in 30 min, although the effect was limited. Changes in AA metabolism in DDC-treated cells may have a potential role in mediating neurotoxic actions of disulfiram. In this study, we show the first to demonstrate the up-regulation of cPLA{sub 2}{alpha} expression by DDC treatment in neuronal cells.
- OSTI ID:
- 20850409
- Journal Information:
- Toxicology and Applied Pharmacology, Vol. 215, Issue 2; Other Information: DOI: 10.1016/j.taap.2006.02.013; PII: S0041-008X(06)00085-8; Copyright (c) 2006 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
- Country of Publication:
- United States
- Language:
- English
Similar Records
Regulation of heme oxygenase-1 expression and MAPK pathways in response to kaempferol and rhamnocitrin in PC12 cells
Macrophage activation by factors released from acetaminophen-injured hepatocytes: Potential role of HMGB1